FORM 20-F Grupo Casa Saba, S.A.B. de C.V.

Table of Contents
For a more detailed description of the Mexican private pharmaceutical market and our private pharmaceutical business, see “Item 4. Information on the Company—
Business Overview—Pharmaceutical Industry”.
The following table sets forth our net sales by division and the corresponding growth rates for each of our business divisions for the years indicated.
Year Ended December 31,
2009 2010 2011
Pharmaceuticals:
Private sector 22,377.4 24,335.4 21,497.2
% Growth 3.9% 8.8% (11.7)%
Government 906.1 959.3 1,209.1
% Growth (12.4)% 5.9% 26.0%
Health, Beauty, Consumer Goods, General Merchandise and Other Products 2,530.4 2,173.6 2,421.8
% Growth 0.4% -14.1% 11.4%
Publications 753.4 835.5 792.6
% Growth 0.6% 10.9% -5.2%
Retail Pharmacy 3,224.3 5,536.9 20,647.5
% Growth 26.3% 71.7% 272.9%
Total 29,791.6 33,840.8 46,568.2
Total % Growth 4.9% 13.6% 37.6%
indicated:
The following table sets forth the net sales for each of our business divisions and our results of operations as a percentage of our total net sales for the years
Year Ended December 31,
2009 2010 2011
Pharmaceuticals:
- Private 75.11% 71.91% 46.16%
- Government 3.04% 2.83% 2.60%
Health, Beauty, Consumer Goods, General Merchandise & Other Products 8.49% 6.42% 5.20%
Publications 2.53% 2.47% 1.70%
Retail Pharmacy 10.82% 16.36% 44.34%
Total 100% 100%
Cost of Sales 89.2% 86.6% 81.2%
Gross Profit 10.8% 13.4% 18.8%
Operating expenses:
- Selling expenses 3.1% 3.7% 2.9%
- Administrative expenses 4.7% 7.7% 12.6%
7.8% 11.4% 15.5%
Operating income 3.0% 2.0% 3.4%
Comprehensive cost of financing, net 0.9% 0.8% 2.2%
Other income 0.5% 0.3% 0.3%
Income tax and employee profit sharing 0.7% 0.1% 0.7%
Net income 0.9% 0.8% 0.2%
For a more detailed description of each of our divisions, see “Item 4. Information on the Company—Operations”.
65